Xiao Albert Zhou

Xiao Albert Zhou

Auto-generated profile, based on publicly available information

Xiao Albert Zhou

Department of Radiation Medicine, School of Basic Medical Sciences, Peking University International Cancer Institute, Institute of Advanced Clinical Medicine, State Key Laboratory of Molecular Oncology, Peking University Health Science Center

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in Molecular Cell
Verified
Journal Article
Closed access
YBYongtai Bai
Yongtai Bai
WWWeibin Wang
Weibin Wang
SLSiyu Li
Siyu Li
JZJun Zhan
Jun Zhan
HLHanxiao Li
Hanxiao Li
JWJiadong Wang
Jiadong Wang

27 October 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
XZXiao Albert Zhou
Xiao Albert Zhou
JZJiadong Zhou
Jiadong Zhou
Long ZhaoLong Zhao
Long Zhao
GYGuihui Yu
Guihui Yu
JZJun Zhan
Jun Zhan
JWJiadong Wang
Jiadong Wang
Significance: Aberrant PD-1 expression is known to inhibit T cell effector activity and plays a pivotal role in tumor immune escape. Since maintaining an appropriate level of PD-1 expression is of great significance, it should be highly regulated at multiple levels. Despite extensive studies to date on this topic, it remains unclear how PD-1 expression is precisely regulated at the posttranslation level both during T cell activation and among the tumor microenvironment. Here, we show that KLHL22 maintains PD-1 protein homeostasis by degrading incompletely glycosylated PD-1, thereby preventing excessive T cell suppression. KLHL22-mediated degradation of PD-1 protein will be ineffective in response to either the tumor microenvironment or treatment with 5-FU, resulting in excessive PD-1 accumulation and reduced T cell activity.

2 January 2024 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
JWJian Wang
Jian Wang
YCYuke Chen
Yuke Chen
SLShiwei Li
Shiwei Li
WLWanchang Liu
Wanchang Liu
XZXiao Albert Zhou
Xiao Albert Zhou
JWJiadong Wang
Jiadong Wang
Mutations in the BRCA2 tumor suppressor gene have been associated with an increased risk of developing prostate cancer. One of the paradoxes concerning BRCA2 is the fact that its inactivation affects genetic stability and is deleterious for cellular and organismal survival, while BRCA2-mutated cancer cells adapt to this detriment and malignantly proliferate. Therapeutic strategies for tumors arising from BRCA2 mutations may be discovered by understanding these adaptive mechanisms. In this study, we conducted forward genetic synthetic viability screenings in Caenorhabditis elegans brc-2 (Cebrc-2) mutants and found that Ceubxn-2 inactivation rescued the viability of Cebrc-2 mutants. Moreover, loss of NSFL1C, the mammalian ortholog of CeUBXN-2, suppressed the spindle assembly checkpoint (SAC) activation and promoted the survival of BRCA2-deficient cells. Mechanistically, NSFL1C recruited USP9X to inhibit the polyubiquitination of AURKB and reduce the removal of AURKB from the centromeres by VCP, which is essential for SAC activation. SAC inactivation is common in BRCA2-deficient prostate cancer patients, but PP2A inhibitors could reactivate the SAC and achieve BRCA2-deficient prostate tumor synthetic lethality. Our research reveals the survival adaptation mechanism of BRCA2-deficient prostate tumor cells and provides different angles for exploring synthetic lethal inhibitors in addition to targeting DNA damage repair pathways.

22 January 2026 in Nucleic Acids Research
Verified
Journal Article
Open access
YMYujie Ma
Yujie Ma
TZTianyi Zhang
Tianyi Zhang
XZXiao Albert Zhou
Xiao Albert Zhou
ZXZhanzhan Xu
Zhanzhan Xu
JZJiadong Zhou
Jiadong Zhou
JWJiadong Wang
Jiadong Wang
The spatial distribution and dynamics of double-strand break (DSBs) repair controlled by microtubules are essential for preserving genomic stability. However, the processes through which extranuclear microtubules govern intranuclear DSB repair across the nuclear envelope (NE) remain poorly understood. This study uncovers a mechanism by which the microtubule-depolymerizing kinesin KIF2A regulates nonhomologous end joining (NHEJ) repair by mediating NE invagination. Our investigation reveals that damage-induced α-tubulin tyrosination triggers KIF2A binding to microtubules, subsequently inducing NE invagination through the microtubule-the linker of nucleoskeleton and cytoskeleton (LINC) complex and lamin B1. This invagination, in turn, provides a larger region of a stable NHEJ repair environment close to the NE, facilitating efficient NHEJ repair. Loss of KIF2A disrupts the formation of invaginations after DNA damage, impacting the formation of 53BP1 foci. Our study establishes KIF2A-mediated NE invagination as a critical regulator of the intricate relationships among microtubules, NE dynamics, and NHEJ repair, shedding light on a previously obscure pathway crucial for genome stability.

7 January 2026 in eLife
Verified
Journal Article
Open access
JZJiadong Zhou
Jiadong Zhou
XZXiao Albert Zhou
Xiao Albert Zhou
LHLi Hu
Li Hu
YMYujie Ma
Yujie Ma
JZJun Zhan
Jun Zhan
JWJiadong Wang
Jiadong Wang
BRCA1 is a critical tumor suppressor, mutations in which greatly increase risks for many tumors in carriers, most notably breast cancer. Luminal progenitor cells (LPs) are the currently recognized cells of origin of BRCA1-deficient breast cancers. However, the reason why LPs are prone to transform with BRCA1 deficiency has not been elucidated. Here, using single-cell sequencing of human BRCA1 mutant breast cancers and RNA sequencing (RNA-seq) of BRCA1 -deficient normal mammary cells, we reveal that replication stress is a feature of LPs and a driving factor during BRCA1-associated tumorigenesis. Mechanistically, replication stress and BRCA1 deficiency lead to significant upregulation of ELF3 expression. ELF3 can help suppress excessive genomic instability and promote LP transformation with BRCA1 deficiency. Moreover, ELF3 emerged as a core transcription factor regulating LP genes, leading to LP expansion. Our findings suggest that replication stress is a driving factor during BRCA1-associated tumorigenesis in luminal progenitor cells and elucidates the key role of ELF3 during this process.